Author

François Singh

University of DundeeORCID 0000-0002-1696-9815Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

François Singh1 paper

Biology Disciplines

Click to filter author papers

Neuroscience· 1 Systems Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:proteomics· 2 Approach:statistical model· 2 Research Focus:benchmarking· 1 Research Focus:drug response / drug discovery· 1 Research Focus:protein structure prediction· 1

Frequent Co-Authors

Alan R. PrescottiD· 1 shared Alastair D. ReithiD· 1 shared Alejandro J. BrenesiD· 1 shared Angus I. LamondiD· 1 shared Anna TasegianiD· 1 shared Carmen Espejo-SerranoiD· 1 shared Dario R. AlessiiD· 1 shared Doreen Ann CantrelliD· 1 shared

Activity by Year

2021-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperSystems Biology

Alan R. PrescottORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Systems BiologyeLifePeer-reviewedOct 28, 2024

Proteomic and functional comparison between human induced and embryonic stem cells

Alejandro J. Brenes, Eva Griesser, Linda V. Sinclair…·Angus I. Lamond

This study compares the proteomes of human induced pluripotent stem cells (hiPSCs) and embryonic stem cells (hESCs), finding quantitative differences in protein expression affecting growth, metabolism, and secreted factors.

3 citations

humanproteomics

𝕏 PostBluesky

NeuroscienceBiochemical JournalPeer-reviewedSep 13, 2021

Impact of Type II LRRK2 inhibitors on signalling and mitophagy

Anna Tasegian, François Singh, Ian G. Ganley…·Dario R. Alessi

This study compares Type I and Type II LRRK2 inhibitors, showing Type II compounds are more potent against wild-type LRRK2 and fail to dephosphorylate specific biomarker sites, suggesting conformational selectivity.

70 citationstop 3%

humanproteomics

𝕏 PostBluesky